Aug. 20 at 9:00 PM
$AMTM with backlog increasing, EPS is projected to be better this year than last, earnings are proving that. Also, there is a slight revenue dip from last year but nothing major, especially since the market cap
Here is only
$5 billion, which is almost 3x less than annual revenue.
With a P/E less than 10, growing backlog, we will see this gain Amentum (pun intended).
Technicals, strong support at that
$20 base. Lowest this has been is around
$16. Worth buying now and adding on dips when you look at undervalued current P/E vs forward P/E, backlog expanding..
$30 target here which would be still a modest forward P/E of 15.
